Eli Lilly has struck a $2.4 billion deal to buy Dice Therapeutics and its drug discovery and development platform for oral, small molecule therapies for immunological diseases. The big pharma is ...

You still can't get those Arby's D&D dice. But if you're lucky - and quick - you might be able to catch them again one day.